Tilkynning frá OMX | 6.11.

Ossur Hf : Transactions in relation to share buyback program

Announcement from Össur hf. No. 80/2017
Reykjavík, 6 November 2017

On 15 August 2017, Össur hf. initiated a share buy-back program, see Company
announcement no. 59/2017.

The purpose of the share buyback program is to reduce the Company's share
capital and adjust the capital structure by distributing capital to shareholders
in line with the Company's Capital Structure and Dividend Policy. The program
would end no later than 31 July 2018. The Company may purchase up to 5,000,000
shares under the program, corresponding to 1.1% of the current share capital.
The total consideration for shares purchased under the program shall not exceed
USD 10 million.

The following transactions were made under the program in week 12, the period
30 October 2017 - 3 November 2017:

 Date No. of shares Avg. purchase price DKK Transaction Value DKK
 30 October 2017 9,222 29.24 269,685

 31 October 2017 7,347 29.30 215,272

 01 November 2017 1,841 29.10 53,573

 02 November 2017 14,257 29.37 418751

 03 November 2017 14,701 29.31 430,958
 Total   47,368 29.03 1,388,239

Össur acquired 646,052 shares under the program at the average price of DKK
29.68. Following the above transactions Össur's holding of own shares is
8,762,657 corresponding to 2.00% of the Company's total share capital.

The share buyback program was carried out in accordance with Regulation No.
596/2014 of the European Parliament and of the Council on market abuse ("MAR"),
and the Commission delegated regulation No. 2016/1052.

Contact persons:
Jón Sigurðsson, President & CEO                                            Tel:
+354 515 1300
Sveinn Sölvason, CFO
 Tel: +354 515 1300

Össur press releases by e-mail: If you wish to receive Össur press releases by
e-mail please register at the following web-site:

About Össur Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopedics
that help people live a life without limitations. Its business is focused on
improving people's mobility through the delivery of innovative technologies
within the fields of braces, supports and prosthetic limbs. A recognized
"Technology Pioneer", Össur invests significantly in research and product
development; its award-winning designs ensuring a consistently strong position
in the market. Successful patient and clinical outcomes are further empowered
via Össur's educational programs and business solutions.  Headquartered in
Iceland, Össur has major operations in the Americas, Europe and Asia, with
additional distributors worldwide. www.ossur.com
Forward-Looking Statement This press release includes "forward-looking
statements" which involve risks and uncertainties that could cause actual
results to differ materially from results expressed or implied by these
statements. Össur hf. undertakes no obligation and does not intend to update
these forward-looking statements to reflect events or circumstances occurring
after this press release. You are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this press
release. All forward-looking statements are qualified in their entirety by this
cautionary statement.

Share buy back transactions 30.10 - 03.11.2017: 

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ossur Hf via GlobeNewswire